Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Iveric Bio Inc (ISEE)
Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,504,431
  • Shares Outstanding, K 137,783
  • Annual Sales, $ 0 K
  • Annual Income, $ -185,210 K
  • 60-Month Beta 1.07
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 11.48
Trade ISEE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.76
  • Most Recent Earnings $-0.53 on 05/10/23
  • Latest Earnings Date 07/25/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 12.89%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.49
  • Number of Estimates 4
  • High Estimate -0.39
  • Low Estimate -0.56
  • Prior Year -0.41
  • Growth Rate Est. (year over year) -19.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.15 +10.51%
on 06/28/23
39.99 -0.10%
on 07/10/23
+1.83 (+4.80%)
since 06/09/23
3-Month
27.23 +46.74%
on 04/11/23
39.99 -0.10%
on 07/10/23
+12.71 (+46.66%)
since 04/10/23
52-Week
9.39 +325.45%
on 09/02/22
39.99 -0.10%
on 07/10/23
+28.24 (+241.16%)
since 07/08/22

Most Recent Stories

More News
3 Pharma Stocks to Buy for Value Investors

The pharma industry is well-positioned to witness significant growth due to the continuous advancements in artificial intelligence and increasing demand for innovative drugs. Therefore, fundamentally strong...

ALPMY : 11.1500 (+2.01%)
ISEE : 39.95 (+0.38%)
MRK : 126.96 (-0.15%)
TARO : 42.10 (+0.07%)
3 Stocks With MAJOR Growth Potential

Considering the recent robust economic indicators and growing optimism, I think fundamentally strong growth stocks América Móvil (AMX), Astellas Pharma (ALPMY), and Bruker (BRKR) could be ideal investments....

ALPMY : 11.1500 (+2.01%)
AMX : 18.72 (+0.05%)
BRKR : 88.33 (+2.07%)
ISEE : 39.95 (+0.38%)
Astellas Completes Acquisition of Iveric Bio

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has successfully completed the...

ISEE : 39.95 (+0.38%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SYNH, DM, TESS, ISEE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SYNH : 42.98 (+0.02%)
DM : 0.6099 (-0.29%)
TESS : 8.99 (+0.11%)
ISEE : 39.95 (+0.38%)
3 Medical Stock Picks for Investors

As the demand for healthcare products and solutions continues to rise, the medical industry is poised for remarkable growth. Therefore, quality medical stocks Johnson & Johnson (JNJ), AstraZeneca (AZN),...

ALPMY : 11.1500 (+2.01%)
AZN : 64.60 (+0.69%)
ISEE : 39.95 (+0.38%)
JNJ : 162.12 (+0.46%)
3 Value Stocks Investors Want

Strong recent economic data and still-elevated inflation are expected to keep the Fed on track for another interest rate hike next month. With the stock market likely to remain volatile amid rising interest...

ALKS : 30.24 (+1.85%)
ALOT : 17.22 (-2.05%)
ALPMY : 11.1500 (+2.01%)
ISEE : 39.95 (+0.38%)
Why Shares of Annexon Are Plummeting Thursday

Mixed trial results on a geographic atrophy eye drug led investors to sell the biotech stock.

ISEE : 39.95 (+0.38%)
APLS : 63.89 (+3.10%)
ALPMY : 11.1500 (+2.01%)
ANNX : 5.97 (+7.18%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARNC, HMPT, ISEE, CHRA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ARNC : 29.99 (+0.03%)
HMPT : 2.32 (unch)
ISEE : 39.95 (+0.38%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MDWT, ARNC, ISEE, CHRA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

MDWT : 26.99 (unch)
ARNC : 29.99 (+0.03%)
ISEE : 39.95 (+0.38%)
IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of IVERIC bio, Inc. (NasdaqGS: ISEE) to Astellas...

ISEE : 39.95 (+0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

IVERIC bio Inc. is a biotechnology company. It is focused on the discovery and development of novel gene therapy solutions to treat orphan inherited retinal diseases. IVERIC bio Inc., formerly known as Ophthotech Corporation, is based in New York, United States.

See More

Key Turning Points

3rd Resistance Point 40.15
2nd Resistance Point 40.07
1st Resistance Point 40.01
Last Price 39.95
1st Support Level 39.87
2nd Support Level 39.79
3rd Support Level 39.73

See More

52-Week High 39.99
Last Price 39.95
Fibonacci 61.8% 28.30
Fibonacci 50% 24.69
Fibonacci 38.2% 21.08
52-Week Low 9.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar